Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$366,262,717
+$11,866,231 QoQ
Shares Held
10,349,328
-19.1% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#12
of 489 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. ROIV ranks #1 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
This page
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in ROIV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $366,262,717 | 10,349,328 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $354,396,486 | 12,794,097 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $231,710,299 | 10,677,894 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $109,425,954 | 7,232,383 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $23,468,456 | 2,082,383 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $38,543,628 | 3,819,983 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $67,667,398 | 5,719,983 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $66,409,641 | 5,754,735 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $41,590,328 | 3,934,752 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $41,472,286 | 3,934,752 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $59,238,250 | 5,275,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $72,416,000 | 6,200,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $111,790,224 | 11,090,300 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $109,821,226 | 14,880,925 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $71,897,527 | 8,998,439 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,914,000 | 3,700,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,070,000 | 1,000,000 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||